Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 5

Abstract

Background. Bacterial infections are frequent complications in patients with cirrhosis. Since they are associated with poor outcomes, antibiotics are frequently over-prescribed. Surrogate markers of bacterial infections, like procalcitonin, are needed to better discriminate between infected and not infected patients. Aims. To evaluated the diagnostic accuracy of an ultra-sensitive procalcitonin assay for the diagnosis of bacterial infections in patients with cirrhosis. Material and methods. In a single-center prospective study, we determined the basal levels of procalcitonin in 106 episodes of admissions to the emergency department in 84 cirrhotic patients. Patients were classified as infected or not infected by two independent hepatologists blinded to the procalcitonin result. Results. The prevalence of bacterial infection was 28% (29 episodes). The median procalcitonin was significantly higher in the infected group than in the not infected group (0.45 vs. 0.061 ng/mL, p < 0.001). The diagnostic accuracy of procalcitonin for bacterial infection estimated by the ROC curve was 0.95 (CI: 95%, 0.91-0.99). When selecting a cutoff value of 0.098 ng/mL a sensitivity of 97% and a negative predictive value 98% were found. Conclusions. The use of an ultra-sensitive procalcitonin assay identifies patients with cirrhosis at very low risk of bacterial infections.

Authors and Affiliations

Sebastián Marciano, Leila Haddad, Alfredo Pedro Martínez, María L. Posadas, Federico Piñero, Gonzalo J. Mora, Laura N. Guerrero, Ezequiel Ridruejo, Oscar G. Mandó, Diego H. Giunta, Adrián C. Gadano

Keywords

Related Articles

Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study

Aims. To define if there is an imbalance in plasma levels of proinflammatory, fibrogenic and antifibrogenic cytokines in patients with liver cirrhosis (LC) and impaired glucose tolerance (IGT) or diabetes mellitus (DM)....

Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells

Background. Endothelial dysfunction has been previously described in metabolic syndrome patients. The levels of circulating endothelial progenitor cells (EPCs) inversely correlates with the incidence of cardiovascular di...

Prevention of hepatocellular carcinoma

Because of its frequency and grave prognosis, preventing hepatocellular carcinoma is an urgent priority. Prevention should be possible because environmental carcinogens-chronic hepatitis B and C virus infections, dietary...

Download PDF file
  • EP ID EP78438
  • DOI -
  • Views 129
  • Downloads 0

How To Cite

Sebastián Marciano, Leila Haddad, Alfredo Pedro Martínez, María L. Posadas, Federico Piñero, Gonzalo J. Mora, Laura N. Guerrero, Ezequiel Ridruejo, Oscar G. Mandó, Diego H. Giunta, Adrián C. Gadano (2014). Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis. Annals of Hepatology, 13(5), 541-547. https://europub.co.uk/articles/-A-78438